Huawei presented during ESC Congress 2026 its new health research ecosystem in Europe, called Terve Research. This European health platform represents a significant step in the company's strategy to expand its presence in the wearable technology market for medical purposes on the continent.
In parallel, the company unveiled the Huawei Watch D3, a smartwatch that obtained CE certification for Ambulatory Blood Pressure Monitoring. This certification allows the device to be used for clinical blood pressure measurements outside the hospital setting.
ESC Congress 2026 served as the backdrop for these announcements, demonstrating Huawei's interest in positioning its wearable devices as legitimate medical tools in the European health device market.
